Captiva Verde Wellness Corp. (PWR.CN)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -6.05 Million CAD | 16.76% |
| 2022 | - CAD | 66.26% |
| 2021 | -924.21 Thousand CAD | -100.56% |
| 2020 | -1.85 Million CAD | -72.27% |
| 2019 | - CAD | -463.61% |
| 2018 | -17.54 Thousand CAD | -13.82% |
| 2017 | -11.96 Thousand CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -482.69 Thousand CAD | 100.0% |
| 2024 Q2 | -932.32 Thousand CAD | 0.0% |
| 2024 Q3 | -2.89 Million CAD | 0.0% |
| 2023 Q1 | -252.76 Thousand CAD | 92.05% |
| 2023 Q4 | -277.53 Thousand CAD | -13.57% |
| 2023 FY | - CAD | 16.76% |
| 2023 Q3 | -244.37 Thousand CAD | 14.96% |
| 2023 Q2 | -287.36 Thousand CAD | -13.69% |
| 2022 Q4 | -3.17 Million CAD | -946.74% |
| 2022 Q3 | -303.66 Thousand CAD | -65.3% |
| 2022 Q1 | 2.4 Million CAD | 172.71% |
| 2022 Q2 | -183.7 Thousand CAD | -107.65% |
| 2022 FY | - CAD | 66.26% |
| 2021 FY | - CAD | -100.56% |
| 2021 Q2 | -129.06 Thousand CAD | 56.07% |
| 2021 Q3 | -137.85 Thousand CAD | -6.81% |
| 2021 Q4 | -3.3 Million CAD | -2296.44% |
| 2021 Q1 | -293.78 Thousand CAD | -71.36% |
| 2020 FY | - CAD | -72.27% |
| 2020 Q1 | -1.06 Million CAD | -1375.15% |
| 2020 Q2 | -280.61 Thousand CAD | 73.65% |
| 2020 Q3 | -357.11 Thousand CAD | -27.26% |
| 2020 Q4 | -171.44 Thousand CAD | 51.99% |
| 2019 Q4 | -72.18 Thousand CAD | 32.87% |
| 2019 Q3 | -107.52 Thousand CAD | 71.79% |
| 2019 Q2 | -381.14 Thousand CAD | 27.19% |
| 2019 Q1 | -523.48 Thousand CAD | -340.62% |
| 2019 FY | - CAD | -463.61% |
| 2018 Q4 | -118.8 Thousand CAD | -608.64% |
| 2018 FY | - CAD | -13.82% |
| 2018 Q3 | -16.76 Thousand CAD | -120.74% |
| 2018 Q2 | -7595.00 CAD | 78.29% |
| 2018 Q1 | -34.97 Thousand CAD | 46.35% |
| 2017 Q3 | -28.83 Thousand CAD | 61.56% |
| 2017 Q4 | -65.19 Thousand CAD | -126.12% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 Q2 | -75 Thousand CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 0.29% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | -201.224% |
| Blueberries Medical Corp. | -1.22 Million CAD | -395.673% |
| The BC Bud Corporation | -1.19 Million CAD | -406.355% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 6.608% |
| CordovaCann Corp. | -1.6 Million CAD | -277.887% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | -130.844% |
| Captor Capital Corp. | 2.42 Million CAD | 350.13% |
| City View Green Holdings Inc. | -2.01 Million CAD | -200.63% |
| 1CM Inc. | 1.31 Million CAD | 561.055% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | -24326.568% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -174.23% |
| IM Cannabis Corp. | -2.79 Million CAD | -117.064% |
| Lobe Sciences Ltd. | -4.4 Million CAD | -37.567% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -1444.067% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | -89.667% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 630.49% |
| Ovation Science Inc. | -778.83 Thousand CAD | -677.585% |
| Pharmadrug Inc. | -1.33 Million CAD | -353.634% |
| RAMM Pharma Corp. | -6.3 Million CAD | 3.904% |
| RIV Capital Inc. | -20.28 Million CAD | 70.138% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | -8.241% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 92.195% |
| SLANG Worldwide Inc. | -2.95 Million CAD | -105.241% |
| 1933 Industries Inc. | -10.03 Million CAD | 39.638% |
| Red Light Holland Corp. | -5.25 Million CAD | -15.225% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | -688.559% |
| Xebra Brands Ltd. | -1.49 Million CAD | -305.09% |
| Adastra Holdings Ltd. | -1.41 Million CAD | -329.124% |